Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quinapril for Diabetic Autonomic and Peripheral Neuropathy
NCT03031834Phase 4Completed
- Sponsor
- Aristotle University of Thessaloniki
- Start
- Jan 1999
- Primary completion
- May 2001
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of quinapril in diabetic autonomic neuropathy (DAN) and diabetic peripheral neuropathy (DPN) (2 arms), sponsored by Aristotle University of Thessaloniki. Primary endpoints: Changes in R-R variation during deep breathing at 2 years, Changes in response to Valsalva maneuver at 2 years and 2 more. Started Jan 1999; status: completed.
02
Drugs
quinapril
03
Conditions
diabetic autonomic neuropathy (DAN)diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT03031834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03031834.